- Home
- ABVC vs BDSX Comparison
ABVC vs BDSX Comparison
Compare ABVC & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABVC
- BDSX
- Stock Information
- Founded
- ABVC 2015
- BDSX 2005
- Country
- ABVC United States
- BDSX United States
- Employees
- ABVC N/A
- BDSX N/A
- Industry
- ABVC Biotechnology: Pharmaceutical Preparations
- BDSX Precision Instruments
- Sector
- ABVC Health Care
- BDSX Health Care
- Exchange
- ABVC Nasdaq
- BDSX Nasdaq
- Market Cap
- ABVC 52.1M
- BDSX 61.9M
- IPO Year
- ABVC N/A
- BDSX 2020
- Fundamental
- Price
- ABVC $3.24
- BDSX $7.75
- Analyst Decision
- ABVC
- BDSX Strong Buy
- Analyst Count
- ABVC 0
- BDSX 5
- Target Price
- ABVC N/A
- BDSX $32.50
- AVG Volume (30 Days)
- ABVC 103.1K
- BDSX 117.3K
- Earning Date
- ABVC 11-13-2025
- BDSX 10-31-2025
- Dividend Yield
- ABVC N/A
- BDSX N/A
- EPS Growth
- ABVC N/A
- BDSX N/A
- EPS
- ABVC N/A
- BDSX N/A
- Revenue
- ABVC $391,242.00
- BDSX $76,556,000.00
- Revenue This Year
- ABVC $735.18
- BDSX $18.80
- Revenue Next Year
- ABVC N/A
- BDSX $27.76
- P/E Ratio
- ABVC N/A
- BDSX N/A
- Revenue Growth
- ABVC 186.84
- BDSX 25.70
- 52 Week Low
- ABVC $0.40
- BDSX $3.44
- 52 Week High
- ABVC $5.48
- BDSX $34.40
- Technical
- Relative Strength Index (RSI)
- ABVC 61.30
- BDSX 68.49
- Support Level
- ABVC $2.99
- BDSX $7.36
- Resistance Level
- ABVC $3.39
- BDSX $7.95
- Average True Range (ATR)
- ABVC 0.17
- BDSX 0.53
- MACD
- ABVC 0.02
- BDSX -0.21
- Stochastic Oscillator
- ABVC 74.23
- BDSX 37.51
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
About BDSX Biodesix Inc.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.